全文获取类型
收费全文 | 2541篇 |
免费 | 135篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 58篇 |
妇产科学 | 37篇 |
基础医学 | 318篇 |
口腔科学 | 68篇 |
临床医学 | 195篇 |
内科学 | 610篇 |
皮肤病学 | 80篇 |
神经病学 | 260篇 |
特种医学 | 108篇 |
外科学 | 213篇 |
综合类 | 12篇 |
预防医学 | 123篇 |
眼科学 | 100篇 |
药学 | 247篇 |
中国医学 | 34篇 |
肿瘤学 | 206篇 |
出版年
2023年 | 20篇 |
2022年 | 34篇 |
2021年 | 57篇 |
2020年 | 49篇 |
2019年 | 37篇 |
2018年 | 53篇 |
2017年 | 48篇 |
2016年 | 57篇 |
2015年 | 55篇 |
2014年 | 87篇 |
2013年 | 99篇 |
2012年 | 170篇 |
2011年 | 205篇 |
2010年 | 106篇 |
2009年 | 94篇 |
2008年 | 185篇 |
2007年 | 217篇 |
2006年 | 181篇 |
2005年 | 185篇 |
2004年 | 175篇 |
2003年 | 156篇 |
2002年 | 143篇 |
2001年 | 21篇 |
2000年 | 10篇 |
1999年 | 22篇 |
1998年 | 35篇 |
1997年 | 27篇 |
1996年 | 17篇 |
1995年 | 18篇 |
1994年 | 10篇 |
1993年 | 22篇 |
1992年 | 5篇 |
1991年 | 8篇 |
1990年 | 13篇 |
1989年 | 6篇 |
1988年 | 6篇 |
1987年 | 5篇 |
1985年 | 5篇 |
1984年 | 6篇 |
1983年 | 3篇 |
1982年 | 3篇 |
1981年 | 4篇 |
1979年 | 3篇 |
1978年 | 4篇 |
1977年 | 2篇 |
1976年 | 5篇 |
1975年 | 3篇 |
1974年 | 4篇 |
1973年 | 2篇 |
1969年 | 2篇 |
排序方式: 共有2691条查询结果,搜索用时 0 毫秒
81.
82.
Nerome Y Imanaka H Nonaka Y Tsuru Y Maeno N Takezaki T Mori H Akaike H Kubota T Kawano Y Takei S 《Modern rheumatology / the Japan Rheumatism Association》2008,18(2):189-192
We report a 27-year-old case of juvenile idiopathic arthritis (JIA) having been stopped infliximab during pregnancy. She was
safely treated by infliximab therapy with premedications for preventing infusin reactions after her delivery, and then improved
in the same manner as when she had been treated with infliximab therapy before pregnancy. As a result, it remains unclear
whether or not we can use infliximab to control disease activities during pregnancy. In addition, it is also important to
clarify whether or not premedications should be used when resuming infliximab treatment in such patients after pregnancy.
These problems still remain controversial. More definitive data are needed in order to allow rheumatologists to better select
the optimal TNF-alpha inhibitor therapy when treating pregnant JIA patients. 相似文献
83.
Nagao Y Hanada S Shishido S Ide T Kumashiro R Ueno T Sata M 《Journal of gastroenterology and hepatology》2003,18(3):258-266
Background and Aim: Hepatitis viruses induce not only chronic liver diseases but also the impairment of other organs and tissues as extrahepatic manifestations. In particular, hepatitis C virus (HCV) is involved in various extrahepatic manifestations. The purpose of the present study was to evaluate Sjögren's syndrome (SS) and lichen planus (LP) involvement, which are various extrahepatic manifestations in patients with liver diseases related to hepatitis B virus (HBV) or HCV. Methods: We examined a total of 110 Japanese patients with chronic liver disease: 29 with HBV infections and 81 HCV infections. Results: The prevalence of SS according to European and Japanese criteria in patients with chronic HCV infection was significantly higher than in patients with chronic HBV infection (European criteria: 25.9 vs 3.4%; P < 0.05, Japanese criteria: 21.0 vs 3.4%; P = 0.05). Lichen planus was observed in one (3.4%) of 29 patients with chronic HBV infection, and in 11 (13.6%) of 81 patients with chronic HCV infection. Simultaneously combined LP and SS occurred in 8.6% (seven of 81) of patients with HCV infection, but in none with HBV infection. Conclusions: Clinicians should routinely follow the HCV‐infected patients, paying sufficient attention to the presence of SS and LP, and they should also carefully monitor their prognosis. 相似文献
84.
Hitoshi Higuchi Akiko Yabuki Minako Ishii-Maruhama Yumiko Tomoyasu Shigeru Maeda Takuya Miyawaki 《Anesthesia progress》2014,61(4):150-154
Adrenaline (epinephrine) is included in dental local anesthesia for the purpose of vasoconstriction. In Japan, adrenaline is contraindicated for use in patients receiving antipsychotic therapy, because the combination of adrenaline and an antipsychotic is considered to cause severe hypotension; however, there is insufficient evidence supporting this claim. The purpose of the present study was to clarify the changes in hemodynamics caused by drug interaction between adrenaline and an antipsychotic and to evaluate the safety of the combined use of adrenaline and an antipsychotic in an animal study. Male Sprague-Dawley rats were anesthetized with sodium pentobarbital. A catheter was inserted into the femoral artery to measure blood pressure and pulse rate. Rats were pretreated by intraperitoneal injection of chlorpromazine or chlorpromazine and propranolol, and after 20 minutes, saline or 1 of 3 different doses of adrenaline was administered by intraperitoneal injection. Changes in the ratio of mean arterial blood pressure and pulse rate were measured after the injection of adrenaline. Significant hypotension and tachycardia were observed after the injection of adrenaline in the chlorpromazine-pretreated rats. These effects were in a dose-dependent manner, and 100 μg/kg adrenaline induced significant hemodynamic changes. Furthermore, in the chlorpromazine and propranolol–pretreated rats, modest hypertension was induced by adrenaline, but hypotension and tachycardia were not significantly shown. Hypotension was caused by a drug interaction between adrenaline and chlorpromazine through the activation of the β-adrenergic receptor and showed a dose-dependent effect. Low-dose adrenaline similar to what might be used in human dental treatment did not result in a significant homodynamic change.Key Words: Local anesthesia, Drug interaction, Adrenaline, Epinephrine, AntipsychoticsVasoconstrictors are included in local anesthetics to increase the duration of anesthesia, to prevent local anesthesia systemic toxicity, and to promote hemostasis in the local operative field.1 Adrenaline (epinephrine) is the most common vasoconstrictor that is added to local anesthetics, and lidocaine and articaine with adrenaline are the most widely used local anesthetics for dental treatment. However, adrenaline has drug interactions with some medicines. It is widely believed that the combination of adrenaline with an antipsychotic can cause hypotension because antipsychotics have α-adrenergic blocker effects that can result in decreased peripheral resistance, and adrenaline has been shown to have significant β2-adrenergic mediated vasodilatory effects that also can cause hypotension. Therefore, the combination of adrenaline and an antipsychotic is contraindicated in Japan for fear of causing significant hypotension. However, there is insufficient evidence supporting this claim, and, in clinical settings, there are many situations in which the use of local anesthetics with adrenaline is appropriate for dental treatment of patients receiving antipsychotic therapy. Thus, the purpose of the present study was to clarify the changes in hemodynamics caused by a drug interaction between adrenaline and an antipsychotic and to evaluate the safety of the combined use of adrenaline with an antipsychotic in an animal study. 相似文献
85.
Hideyuki Shiba Tohru Takeuchi Kentaro Isoda Yasuhito Kokunai Yumiko Wada Shigeki Makino Toshiaki Hanafusa 《Rheumatology international》2014,34(9):1319-1322
Autoimmune disorder is one of the important side effects of interferon-α therapy. Some polymyositis cases as complication of interferon-α therapy were reported, but dermatomyositis were rarely. We report a case of dermatomyositis as a complication of interferon-α therapy for hepatitis C. A 52-year-old Japanese man was treated by combination therapy with pegylated interferon-α-2b and ribavirin for hepatitis C. Three months after the initiation of therapy, he showed erythema in the posterior cervical to dorsal and anterior cervical to thoracic regions, weight loss, general malaise, muscle pain, and severe increase in levels of muscle enzymes. We made a diagnosis of dermatomyositis according to these clinical features, proximal muscle-predominant myogenic change on electromyography, and infiltration of monocytes and CD4+-dominant lymphocytes on skin biopsy, although myositis-associated antibodies were absent. He was successfully treated with intravenous immunoglobulin and tacrolimus in addition to glucocorticoid. This is a very rare case of dermatomyositis associated with interferon-α therapy. We reviewed several similar published cases and the association of dermatomyositis and type I interferon. 相似文献
86.
Masashi TSUNODA Takamasa KIDO Sachiyo MOGI Yumiko SUGIURA Eriko MIYAJIMA Yuichiro KUDO Tatenao KUMAZAWA Yoshiharu AIZAWA 《Industrial health》2014,52(5):439-444
Glass wool and continuous glass filaments have been used in industry. We examined the
irritability of those among Japanese. A patch test was performed on 43 volunteers for the
followings: glass wool for non-residential use with and without a urea-modified phenolic
resin binder, that for residential use with and without the binder, and continuous glass
filaments with diameters of 4, 7, 9, and 13 µm. Materials
were applied to an upper arm of each volunteer for 24 h. The skin was observed at 1 and
24 h after the removal. At 1 h after removal, slight erythema was observed on the skin of
a woman after the exposure to glass wool for residential use without the binder. Erythema
was observed on the skin of another woman at 1 h after a 24-h exposure to glass wool for
non-residential use without the binder. There were no reactions at 24 h after the removal.
The low reactions in the patch test suggested that the irritability caused by glass wool,
irrespective of a resin component, could be induced mechanically, and that the
irritability caused by continuous glass filaments with resin could be slight and either
mechanical or chemical. 相似文献
87.
88.
89.
Tetsu Mukai Yumiko Tsukamoto Yumi Maeda Toshiki Tamura Masahiko Makino 《Clinical and Vaccine Immunology : CVI》2014,21(1):1-11
For the purpose of obtaining Mycobacterium bovis bacillus Calmette-Guérin (BCG) capable of activating human naive T cells, urease-deficient BCG expressing a fusion protein composed of Mycobacterium tuberculosis-derived major membrane protein II (MMP-II) and heat shock protein 70 (HSP70) of BCG (BCG-DHTM) was produced. BCG-DHTM secreted the HSP70-MMP-II fusion protein and effectively activated human monocyte-derived dendritic cells (DCs) by inducing phenotypic changes and enhanced cytokine production. BCG-DHTM-infected DCs activated naive T cells of both CD4 and naive CD8 subsets, in an antigen (Ag)-dependent manner. The T cell activation induced by BCG-DHTM was inhibited by the pretreatment of DCs with chloroquine. The naive CD8+ T cell activation was mediated by the transporter associated with antigen presentation (TAP) and the proteosome-dependent cytosolic cross-priming pathway. Memory CD8+ T cells and perforin-producing effector CD8+ T cells were efficiently produced from the naive T cell population by BCG-DHTM stimulation. Single primary infection with BCG-DHTM in C57BL/6 mice efficiently produced T cells responsive to in vitro secondary stimulation with HSP70, MMP-II, and M. tuberculosis-derived cytosolic protein and inhibited the multiplication of subsequently aerosol-challenged M. tuberculosis more efficiently than did vector control BCG. These results indicate that the introduction of MMP-II and HSP70 into urease-deficient BCG may be useful for improving BCG for control of tuberculosis. 相似文献
90.
Yu Kitaoka Yumiko Takahashi Masanao Machida Kohei Takeda Tohru Takemasa Hideo Hatta 《The journal of physiological sciences : JPS》2014,64(1):59-64
It is now evident that exercise training leads to increases in monocarboxylate transporter (MCT)1 and MCT4, but little is known about the mechanisms of coupling muscle contraction with these changes. The aim of this study was to investigate the effect of 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside (AICAR) induced activation of AMP-activated protein kinase (AMPK) on MCT1, MCT4, and GLUT4 in denervated muscle. Protein levels of MCT4 and GLUT4 after 10 days of denervation were significantly decreased in mice gastrocnemius muscle, while MCT1 protein levels were not altered. AICAR treatment for 10 days significantly increased MCT4, and GLUT4 protein levels in innervated muscle as shown in previous studies. We found that the MCT1 protein level was also increased in AICAR treated innervated muscle. AICAR treatment prevented the decline in MCT4 and GLUT4 protein levels in denervated muscle. Thus, the current study suggests that MCT1 and MCT4 protein expression in muscles, as well as GLUT4, may be regulated by AMPK-mediated signal pathways, and AMPK activation can prevent denervation-induced decline in MCT4 protein. 相似文献